Parrallel Imports

Paralllel Imports or Parallel trade occurs when products protected by patent,trademark or copyright are first placed into circulation on one market in the EU,then re-imported into a second market within the EU.This trade is safe & highly regulated by the authorities in the importing country and in Europe.

The essential purpose of such trade is arbitrage between countries in the EU with different prices.The manufacturers of original medicines sell their products at different prices within the EU in order to maximise their profits.

Sigma Pharmaceuticals plc offers  a comprehensive range of Parallel Imports.
Together with the range we offer a unique  24hrs stock line that could give our customers information of stocks and availability.Please check with telesales or customer services for a Price/Product list.

Sigma works with most EU countries and holds approximately 800 Parallel Import licences and majority of the imports and processing is carried out in Watford at OPD Laboratories Limited.OPD Laboratories Ltd hold a wide range of MHRA(Medicines Health & Regulatory Agency) & EMEA(European Medicines Evaluation Agency) licences and is fully compliant with the rules & regulations.

Sigma Pharmaceuticals plc/OPD Laboratories Ltd are members of the BAEPD (British Association of European Pharmaceutical Distributors).Please visit the BAEPD web site (www.baepd.co.uk).